Role of the cytosine DNA-methyltransferase and p16(INK4a) genes in the development of mouse lung tumors

Experimental Lung Research

Volumn 24, Issue 4, 1998, Pages 463-479

  Belinsky, Steven A ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Cytosine DNA methyltransferase; Lung cancer; p16; Type II cells

Indexed keywords

CYTOSINE; DNA METHYLTRANSFERASE; PROTEIN P16;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CYCLE S PHASE; CELL ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; DNA TEMPLATE; ENZYME ACTIVITY; GENE DELETION; LUNG ALVEOLUS CELL TYPE 2; LUNG CARCINOGENESIS; LUNG TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION;

EID: 0031831509     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149809087381     Document Type: Conference Paper

References (54)

1. Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet. 1993;3:1487-1495.
2. Singer-Sam J, Riggs AD. X chromosome inactivation and DNA methylation. EXS. 1993;64:358-384.
3. Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev. 1993;7:1663-1673.
4. Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321:209-213.
5. deBustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB. The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci USA. 1988;85:5693-5697.
6. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA. 1992;89:1929-1933.
7. Herman JG, Latif F, Yongkai W, et al. Silencing of the VHL tumor-supressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA. 1994;91:9700-9704.
8. Issa J-PJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 1994;7:536-540.
9. Merlo A, Herman JG, Mao L, et al. CpG island methylation is associated with inactivation of the tumor suppressor CDKN/p16 in human tumors. Nature Med. 1995;1:686-692.
10. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG island methylation in human carcinomas. Proc Natl Acad Sci USA. 1995;92:7416-7419.
11. Makos MW, Biel MA, Deiry WE, et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med. 1995;6:570-577.
12. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855-4878.
13. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
14. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-439.
15. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1995;1:686-692.
16. INK4a protein is restricted to the subset of lung cancer lines that retains wildtype Rb. Oncogene. 1994;9:3375-3378.
17. INK4b genes. Oncogene. 1995;11:635-645.
18. Xiao S, Daizong L, Corson JM, Vijg J, Fletcher JA, Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res. 1995;55:2968-2971.
19. Davis LM, Caspary WJ, Sakallah SA, et al. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis. 1994;15:1637-1645.
20. Herzog CR, Wiseman RW, You M. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res. 1994;54:4007-4010.
21. Funaki K, Everitt J, Oshimura M, Freed JJ, Knudson AG, Walker C. Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6. Cancer Res. 1991;51:4415-4422.
22. Harbour JW, Lai S-L, Whang-Peng J, Gazda AF, Minna JF, Kaye JF. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 1988;241:353-357.
23. Bestor T, Laudano A, Mattaliano R, Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. J Mol Biol. 1988;203:971-983.
24. Issa J-PJ, Vertino PM, Wu J, et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst. 1993;85:1235-1240.
25. Wu J, Issa J-P, Herman J, Bassett DE, Nelkin BD, Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA. 1993;90:8891-8895.
26. Laird PW, Jackson-Grusby L, Fazeli A, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 1995;81:197-205.
27. Belinsky SA, Nikula KJ, Baylin SB, Issa J-PJ. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci. USA. 1996;93:4045-4050.
28. INK4a in mouse lung tumors. Carcinogenesis. 1996;17:101-106.
29. Belinsky SA, Lechner JF, Johnson NF. An improved method for the isolation of type II and Clara cells from mice. In Vitro Cell Dev Biol. 1995;31:361-366.
30. Belinsky SA, Devereux TR, Foley JF, Maronpot RR, Anderson MW. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 1992;52:3164-3173.
31. Adams RLP, Rinaldi A, Seivwright C. Microassay for DNA methyltransferase. J Biochem Biophys Methods. 1991;22:19-22.
32. INK4b genes. Oncogene. 1995;11:635-645.
33. Malkinson A. The genetic basis of susceptibility to lung tumors in mice. Toxicology. 1989;54:241-271.
34. INK4a expression in primary lung cancers and cell lines. Cancer Res. 1995;55:505-509.
35. INK4a tumor suppressor protein. Cancer Res. 1995;55:2503-2506.
36. MacLeod AR, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem. 1995;270:8037-8043.
37. Hammond WG, Yellin A, Gabriel A, et al. Effects of 5-azacytidine in Syrian golden hamsters: toxicity, tumorigenicity, and differential modulation of bronchial carcinogenesis. Exp Mol Pathol. 1990;53:34-51.
38. Antequera F, Boyes J, Bird AP. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. 1990;62:503-514.
39. de Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, Baylin SB. The short arm of chromosome 11 is a "hotspot" for hypermethylation in human neoplasia. Proc Natl Acad Sci USA. 1988;85:5693-5697.
40. INK4ain primary rat lung tumors. Mol Cell Biol. 1997;17:1366-1374.
41. Belinsky SA, Swafford DS, Finch GL, et al. Alterations in the K-ras and p53 genes in rat lung tumors. Environ Health Perspect. 1997;105:901-906.
42. Barker D, Schafer M, White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell. 1984;36:131-138.
43. Rideout WM, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. 1990;249:1288-1290.
44. Hegi M, Devereux TR, Dietrich WF, et al. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalance on chromosome 6 and K-ras activation. Cancer Res. 1994;54:6257-6264.
45. INK4a gene product in human pituitary tumors. Cancer Res. 1996;56:2493-2496.
46. INK4a in human cancer. Proc. Natl. Acad Sci USA. 1994;91:11045-11049.
47. INK4a expression in primary lung cancers and cell lines. Cancer Res. 1995;55:505-509.
48. INK4a expression is frequent in high grade gliomas. Cancer Res. 1995;55:1941-1945.
49. INK4b in undifferentiated mouse skin tumors. Cancer Res. 1995;55:5168-5172.
50. INK4a deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Cancer Res. 1995;55:1607-1612.
51. INK4a-b in mouse lung tumor cells. Oncogene. 1996;13:1885-1891.
52. Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 1992;52:6079-6082.
53. Crowell R, Gilliland FD, Temes RT, et al. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer. Cancer Epidemiol Biomarkers Prev. 1996;5:631-637.
54. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;12:857-862.